New heart drug aims to ease debilitating symptoms in genetic heart condition
Disease control
Recruiting now
This study is testing whether an investigational drug called ninerafaxstat can improve symptoms and exercise ability in people with a genetic heart condition where the heart muscle is abnormally thick. About 165 participants with symptomatic non-obstructive HCM will receive eithe…
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC